Susanne Schaffert new non-Executive Director Galapagos

Susanne Schaffert new non-Executive Director Galapagos

13-06-2023 Galapagos has announced the appointment of Susanne Schaffert as non-Executive Director. Schaffert takes over the position from Rajesh Parekh, who stepped down on June 10, 2023.

After a 27-year career at Novartis during which she held various global positions, Schaffert resigned from her position as President of Novartis Oncology and member of Novartis' Executive Committee in 2022. Currently, she is also a non-Executive Director at Incyte Corporation and Novo Holdings. She also serves on the Novo Advisory Group (NAG) and the Executive Education Board of St. Gallen Business School.

"On behalf of the Galapagos Board of Directors, I am very pleased to welcome Susanne to our Board of Directors," said Paul Stoffels, CEO and president of Galapagos. "Susanne brings a wealth of R&D, regulatory and commercial expertise in oncology, and more specifically in CAR-T therapy. Her operational experience, global network and understanding of the competitive landscape in oncology will provide important perspectives and strategic input to our Board as we continue to work toward delivering transformative medicines to patients."

Susanne Schaffert says she is honored to join Galapagos' Board of Directors. "I look forward to contributing to the company's mission to pioneer for patients and accelerate science and innovation to address important unmet needs."